These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 36828001)

  • 1. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak.
    Azzam A; Khaled H; Salem H; Ahmed A; Heniedy AM; Hassan HS; Hassan A; El-Mahdy TS
    Virol J; 2024 Jun; 21(1):130. PubMed ID: 38840177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
    Fink DL; Callaby H; Luintel A; Beynon W; Bond H; Lim EY; Gkrania-Klotsas E; Heskin J; Bracchi M; Rathish B; Milligan I; O'Hara G; Rimmer S; Peters JR; Payne L; Mody N; Hodgson B; Lewthwaite P; Lester R; Woolley SD; Sturdy A; Whittington A; Johnson L; Jacobs N; Quartey J; Ai Payne B; Crowe S; Elliott IA; Harrison T; Cole J; Beard K; Cusack TP; Jones I; Banerjee R; Rampling T; ; Dunning J
    Lancet Infect Dis; 2023 May; 23(5):589-597. PubMed ID: 36566771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
    Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
    Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
    Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
    Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpox in people with past infection or a complete vaccination course: a global case series.
    Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
    Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between HIV and Severe Mpox in an Atlanta Cohort.
    Aldred B; Scott JY; Aldredge A; Gromer DJ; Anderson AM; Cartwright EJ; Colasanti JA; Hall B; Jacob JT; Kalapila A; Kandiah S; Kelley CF; Lyles RH; Marconi VC; Nguyen ML; Rebolledo PA; Sheth AN; Szabo B; Titanji BK; Wiley Z; Workowski K; Cantos VD
    J Infect Dis; 2024 Mar; 229(Supplement_2):S234-S242. PubMed ID: 38001044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak.
    Pilkington V; Quinn K; Campbell L; Payne L; Brady M; Post FA
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):581-586. PubMed ID: 37071153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Tecovirimat Treatment for Mpox Disease Among People With HIV.
    Aldred B; Lyles RH; Scott JY; Gromer DJ; Aldredge A; Workowski KA; Wiley Z; Titanji BK; Szabo B; Sheth AN; Rebolledo PA; Nguyen ML; Marconi VC; Kelley CF; Kandiah S; Kalapila A; Jacob JT; Hall B; Colasanti JA; Cartwright EJ; Cantos VD
    JAMA Intern Med; 2024 Mar; 184(3):275-279. PubMed ID: 38190312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe.
    Kowalski J; Cielniak I; Garbacz-Łagożna E; Cholewińska-Szymańska G; Parczewski M
    J Med Virol; 2023 Oct; 95(10):e29172. PubMed ID: 37861345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak.
    Essajee NM; Oddo-Moise H; Hagensee ME; Lillis RA; Maffei J; Butler I; Lovett A; Sokol T; Clement ME
    AIDS Res Hum Retroviruses; 2023 Nov; 39(11):587-592. PubMed ID: 37424520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
    Thornhill JP; Palich R; Ghosn J; Walmsley S; Moschese D; Cortes CP; Galliez RM; Garlin AB; Nozza S; Mitja O; Radix AE; Blanco JL; Crabtree-Ramirez B; Thompson M; Wiese L; Schulbin H; Levcovich A; Falcone M; Lucchini A; Sendagorta E; Treutiger CJ; Byrne R; Coyne K; Meyerowitz EA; Grahn AM; Hansen AE; Pourcher V; DellaPiazza M; Lee R; Stoeckle M; Hazra A; Apea V; Rubenstein E; Jones J; Wilkin A; Ganesan A; Henao-Martínez AF; Chow EJ; Titanji BK; Zucker JE; Ogoina D; Orkin CM;
    Lancet; 2022 Dec; 400(10367):1953-1965. PubMed ID: 36403584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, molecular, and histological characteristics of severely necrotic and fatal mpox in HIV-infected patients.
    Rajme-López S; Corral-Herrera EA; Tello-Mercado AC; Tepo-Ponce KM; Pérez-Meléndez RE; Rosales-Sotomayor Á; Figueroa-Ramos G; López-López K; Domínguez-Cherit JG; San-Martín-Morante O; Saeb-Lima M; Gamboa-Domínguez A; Ponce-de-León A; Crabtree-Ramírez B; Ramos-Cervantes P; Ruíz-Palacios GM
    AIDS Res Ther; 2023 Nov; 20(1):85. PubMed ID: 38012656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study.
    Moraes-Cardoso I; Benet S; Carabelli J; Perez-Zsolt D; Mendoza A; Rivero A; Alemany A; Descalzo V; Alarcón-Soto Y; Grifoni A; Sette A; Moltó J; Marc A; Marks M; Mitjà O; Brander C; Paredes R; Izquierdo-Useros N; Carrillo J; Suñer C; Olvera A; Mothe B;
    Lancet Microbe; 2024 Aug; 5(8):100859. PubMed ID: 38857615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study.
    Angelo KM; Smith T; Camprubí-Ferrer D; Balerdi-Sarasola L; Díaz Menéndez M; Servera-Negre G; Barkati S; Duvignaud A; Huber KLB; Chakravarti A; Bottieau E; Greenaway C; Grobusch MP; Mendes Pedro D; Asgeirsson H; Popescu CP; Martin C; Licitra C; de Frey A; Schwartz E; Beadsworth M; Lloveras S; Larsen CS; Guagliardo SAJ; Whitehill F; Huits R; Hamer DH; Kozarsky P; Libman M;
    Lancet Infect Dis; 2023 Feb; 23(2):196-206. PubMed ID: 36216018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mpox and HIV: a Narrative Review.
    Saldana CS; Kelley CF; Aldred BM; Cantos VD
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):261-269. PubMed ID: 37178205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral load monitoring during monkeypox virus infection among people with HIV.
    Raccagni AR; Mileto D; Galli L; Bruzzesi E; Canetti D; Rizzo A; Bertoni C; Clemente T; Alberton F; Castagna A; Nozza S
    AIDS; 2023 Apr; 37(5):779-783. PubMed ID: 36689645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.